Overview:
Over
the past 12 months, the cord blood banking industry has expanded
through double digit growth, due to new entrants in the cord blood
banking industry, as well as revenue growth at existing operations. To
guide industry competitors, this report considers the questions:
· What factors are causing a substantial number of new cord blood banks to open up business?
· What will be the effect of these new entrants to the cord blood banking industry for existing competitors?
· How can existing competitors maintain a position of dominance in the industry among this trend?
Deeper
analysis also reveals that existing cord blood banks follow a bi-modal
distribution, either experiencing flat-line growth (less than 3% per
annum) or substantively building revenue (25% or more per annum).
While
a similar bimodal distribution existed in the prior 12 month period
(trailing 12 to 24 months), the peaks have continued to separate over
the past 12 months, with the average flat-growth company staying
stagnant and the average revenue growth company increasing its per annum
growth rate from 17% per year to 25% per year. This trend indicates an
increasing shift in dominance toward fast-growth companies, which begs
the questions:
· What
are the differences among the cord blood banks that are experiencing
flat-line growth, versus those that have substantively building revenue?
· Why are the fast-growth companies continuing to increase their dominance relative to the flat growth companies?
Over
the past 12 months, there has also been particularly fast industry
growth within specific regions of the world. This report considers the
models and tactics used within those regions in order to identify
strategies that businesses in other regions should consider leveraging
as approaches for growth.
In sum, this expanded and updated version includes:
· Supplemental analysis of factors that have produced double-digit industry growth over the trailing 12 months
· Guidance on how to break through flat-line growth to become a fast-growing competitor within the cord blood industry
· Novel global tactics for growth that can be leveraged without respect to country
· Results
from a detailed survey of expectant parents to provide insight into the
perspectives and decisions of prospective clients
For more information, please visit:
Or email us at press@aarkstore.com or call +919272852585
More Reports
Stem Cell Research Products - Opportunities, Tools, and Technologies
Mesenchymal Stem Cells, Advances & Applications
Capitalizing on Opportunities in Cord Blood Industry Growth
Strategic Development of Neuronal Stem & Progenitor Cell Products
Opportunities in Human Embryonic Stem Cell (hESC) Products
CORD BLOOD BANKING - Comprehensive Industry Database (2012)
Profitable Opportunities in Pharmacodynamic Assay Development
Mesenchymal Stem Cells, Advances & Applications
Capitalizing on Opportunities in Cord Blood Industry Growth
Strategic Development of Neuronal Stem & Progenitor Cell Products
Opportunities in Human Embryonic Stem Cell (hESC) Products
CORD BLOOD BANKING - Comprehensive Industry Database (2012)
Profitable Opportunities in Pharmacodynamic Assay Development
Aarkstore Enterprise
Tel : +912227453309
Mobile No: +919272852585
Email : contact@aarkstore.com
Website : http://www.aarkstore.com
Blog: http://blogs.aarkstore.com/
Follow us on twitter: http://twitter.com/aarkstoredotcom
No comments:
Post a Comment